Arrowhead Pharmaceuticals, Inc. (ARWR)
63.69
+0.55
(+0.87%)
USD |
NASDAQ |
Feb 24, 16:00
62.90
-0.79
(-1.24%)
After-Hours: 16:52
Arrowhead Pharmaceuticals Research and Development Expense (Quarterly) : 171.32M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 218.89M |
| Sanofi | -- |
| Eli Lilly & Co. | 3.802B |
| Cidara Therapeutics, Inc. | 35.53M |
| Celcuity, Inc. | 34.92M |